AP5M1

AP-5 complex subunit mu , otherwise known as MUDENG , is a protein that is encoded by the AP5M1 gene. The AP5M1 gene was originally discovered when screening for genes which helped to promote death in Fas-mediated apoptosis. It is a highly conserved gene.
MuD is the medium-sized subunit of the AP5 [adaptor complex]. MuD is expressed throughout the body and is located within both the mitochondria as well as the endoplasmic reticulum of cells.
MuD has been shown to have the ability to induce apoptosis; however, there is evidence that it plays an anti-apoptotic role in apoptosis mediated by tumor ligand ">necrosis factor-related apoptosis-inducing ligand .

Structure

MuD consists of 490 amino acids that interact to form a tertiary structure with three domains.
The overall structure shares similarities with adaptor protein complexes that are related to clathrin-mediated endocytosis; amino acids 197 through 417 are a shared adaptin domain found in Adaptor [complexes medium subunit domain|AP μ subunits].
Within the adaptin domain are two aspartic acids, D276 and D290, which serve as binding sites for caspase-3.

Function

The overall function of MuD remains unclear. It is known, however, that MuD regulates the expression of BAX, a pro-apoptotic member of the Bcl-2 family of proteins. Due to— and dependent upon— this relationship, MuD has been able to induce cell death in tumor cells.
Additionally, MuD has been suggested to be involved in endosomal trafficking.

TRAIL and MuD

TRAIL, an apoptosis-inducing ligand, activates caspase-8 and caspase-3, which initiate the intrinsic pathway of apoptosis by cleaving BH3 interacting-domain death agonist into tBid, another pro-apoptotic member of the Bl-2 protein family. MuD interferes with this process because D276 and D290 act as alternative binding sites for caspase-3, decreasing the amount of Bid that gets cleaved. Tumor cells being treated with TRAIL are 32% more likely to survive when MuD is being expressed.